Published in Bioconjug Chem on February 16, 2007
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol (2002) 1.79
HIV-1 drug resistance surveillance using dried whole blood spots. Antivir Ther (2007) 1.67
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma. J Clin Oncol (2007) 1.50
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop (2004) 1.34
Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol (2002) 1.14
Importance of halogen···halogen contacts for the structural and magnetic properties of CuX2(pyrazine-N,N′-dioxide)(H2O)2 (X = Cl and Br). Inorg Chem (2012) 1.07
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.06
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma. J Clin Oncol (2005) 1.06
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant (2008) 1.05
New insights on the Chagas disease main vector Triatoma infestans (Reduviidae, Triatominae) brought by the genetic analysis of Bolivian sylvatic populations. Infect Genet Evol (2011) 0.96
Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2005) 0.96
Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting. MAbs (2012) 0.96
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma. Biol Blood Marrow Transplant (2007) 0.94
Polymyxin B enhances ISS-mediated immune responses across multiple species. Cell Immunol (2004) 0.91
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.91
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leuk Res (2004) 0.89
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients. Biol Blood Marrow Transplant (2007) 0.86
Is the interplay between epigenetic markers related to the acclimation of cork oak plants to high temperatures? PLoS One (2013) 0.84
A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production. Eur J Immunol (2003) 0.83
Immunostimulatory DNA as a vaccine adjuvant. Expert Rev Vaccines (2007) 0.83
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol (2003) 0.82
Heterogeneity of uidA gene in environmental Escherichia coli populations. J Water Health (2005) 0.81
Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy. Breast Cancer Res Treat (2013) 0.80
Analysis of hydroxycinnamic acids derivatives in calafate (Berberis microphylla G. Forst) berries by liquid chromatography with photodiode array and mass spectrometry detection. J Chromatogr A (2013) 0.80
Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. Clin Transplant (2011) 0.79
Sequence analysis of the rDNA internal transcribed spacer 2 and polymerase chain reaction identification of Anopheles fluminensis (Diptera: Culicidae: Anopheles) in Bolivia. J Med Entomol (2006) 0.79
Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure. Am J Physiol Heart Circ Physiol (2005) 0.78
Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach. J Cardiothorac Surg (2012) 0.78
Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP. J Surg Res (2006) 0.77
Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1. J Allergy Clin Immunol (2006) 0.76
Hypothermia severely effects performance of nitinol-based endovascular grafts in vitro. Ann Thorac Surg (2012) 0.75
Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy. Eur J Pharmacol (2006) 0.75
Double exchange in a mixed-valent octanuclear iron cluster, [Fe8(μ4-O)4(μ-4-Cl-pz)12Cl4](-). Dalton Trans (2014) 0.75
A case of inclusion body myositis responsive to prednisolone therapy. Clin Rheumatol (2008) 0.75
History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis. Leuk Lymphoma (2014) 0.75
Utility of Three-Dimensional Ultrasonography to Assess the Position of Essure Tubal Occlusion Device and Its Complications. Gynecol Obstet Invest (2016) 0.75
Heartmate II™ device placement five years following ACORN CorCap™ device implantation. J Card Surg (2012) 0.75
Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes. Pharmacology (2005) 0.75
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? Biol Blood Marrow Transplant (2006) 0.75